Study Finds Gut Microbiome Clues May Help Detect Parkinson's Disease Early - Video

What if your gut could quietly signal the early stages of a brain disorder-years before symptoms even begin?

A new study published in Nature Medicine suggests that the answer might lie in the tiny microbes living inside our digestive system. Researchers found that changes in the gut microbiome—the community of bacteria in our intestines—could help identify people who are closer to developing Parkinson’s disease, even before clear symptoms appear.

The study looked at stool samples from 464 people, including those already diagnosed with Parkinson’s, healthy individuals, and people carrying a high-risk gene called GBA1. Interestingly, those at risk showed a “middle” pattern in their gut bacteria—somewhere between healthy individuals and patients. In fact, over 25% of their microbiome reflected this intermediate state.

Scientists also noticed specific bacterial changes. Some microbes, like Bifidobacterium, were increased, while others that normally support gut health were reduced.

To better understand this, researchers created a scoring system called PDMS-16, which tracks these microbial changes. People with higher scores—even if they were otherwise healthy—tended to show early signs associated with Parkinson’s, such as constipation, anxiety, and subtle nervous system issues.

However, there’s an important limitation: this study cannot predict who will definitely develop the disease. It only shows that gut changes may reflect how close someone is to developing it.

In the future, simple gut tests might help doctors detect Parkinson’s earlier, when treatments could be more effective. For now, scientists emphasize that more long-term research is needed. In short, your gut may hold important clues about your brain’s future—but we’re just beginning to understand how to read them.

REFERENCE: Menozzi, E., Ren, Y., Geiger, M., Macnaughtan, J., Avenali, M., Toffoli, M., Gilles, M., Calabrese, R., Mitrotti, P., Gallo, L., Famechon, A., Del Pozo, S. L., Mezabrovschi, R., Koletsi, S., Loefflad, N., Yalkic, S., Limbachiya, N., Clasen, F., Yildirim, S., . . . Schapira, A. H. (2026). Microbiome signature of Parkinson’s disease in healthy and genetically at-risk individuals. Nature Medicine, 1-11. DOI: 10.1038/s41591-026-04318-5, https://www.nature.com/articles/s41591-026-04318-5